The global RNA-targeted small molecules market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The conventional clinical delivery of oligonucleotide-based therapies comes with certain unaddressed challenges of genetic disorders. This unmet medical need has created promising opportunities for the global RNA-targeted small molecules market. The ability of small molecules to target the more complex RNA structures is primarily anticipated to drive market growth. As of 2020, out of the 55 US FDA-approved drugs, more than 65% of them were small molecule therapeutics; the majority of which were conventionally developed to target proteins.
Although just 2% of the human genome is allegedly responsible for coding proteins. This is why, therapies are now focused on evaluating previously untapped targets, such as non-coding DNA and RNA. For instance, in January 2022, HotSpot Therapeutics and Caris Life Sciences had collaborated to advance precision medicine approaches for HotSpot’s emerging product portfolio. The partnership will focus initially on two therapeutic programs, the first of which is HotSpot’s novel allosteric inhibitor of the E3 ubiquitin ligase CBL-B, an important target in cancer immunotherapy, spanning from pre-First in Human (FIH) trials through potential Companion Diagnostics (CDx) and launch.
To Request a Sample of our Report on RNA-Targeted Small Molecules Market: https://www.omrglobal.com/request-sample/rna-targeted-small-molecules-market
The global RNA-targeted small molecules market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The conventional clinical delivery of oligonucleotide-based therapies comes with certain unaddressed challenges of genetic disorders. This unmet medical need has created promising opportunities for the global RNA-targeted small molecules market. The ability of small molecules to target the more complex RNA structures is primarily anticipated to drive market growth. As of 2020, out of the 55 US FDA-approved drugs, more than 65% of them were small molecule therapeutics; the majority of which were conventionally developed to target proteins.
Although just 2% of the human genome is allegedly responsible for coding proteins. This is why, therapies are now focused on evaluating previously untapped targets, such as non-coding DNA and RNA. For instance, in January 2022, HotSpot Therapeutics and Caris Life Sciences had collaborated to advance precision medicine approaches for HotSpot’s emerging product portfolio. The partnership will focus initially on two therapeutic programs, the first of which is HotSpot’s novel allosteric inhibitor of the E3 ubiquitin ligase CBL-B, an important target in cancer immunotherapy, spanning from pre-First in Human (FIH) trials through potential Companion Diagnostics (CDx) and launch.
(Get 15% Discount on Buying this Report)
A full Report of RNA-Targeted Small Molecules Market is Available @ https://www.omrglobal.com/industry-reports/rna-targeted-small-molecules-market
Global RNA Targeted Small Molecules Market Report by Segment
By Product Type
· mRNA Translation Regulation
· RNA Splicing Modification
· Direct RNA Targeting
· Indirect RNA Targeting-Epitranscriptomics
By Application
· Drug Discovery
· Disease Identification
· Oncology Research
By End-User
· Hospitals
· Research Laboratories
· Contract Research Organizations
· Pharmaceutical and Biotechnology Companies
Global RNA Targeted Small Molecules Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
